Novel cancer treatment from Kite Pharma notches positive results, but big questions remain
(By Damian Garde for ST A T) A promising new approach to cancer is moving closer to reaching patients, as
Read More(By Damian Garde for ST A T) A promising new approach to cancer is moving closer to reaching patients, as
Read More(By Katherine Hobson for NPR) People who have reached their later years may think it’s primarily a time to relax,
Read More(By Ed Silverman for ST A T) Diabetes 1 may be a widespread disease for which millions of people need
Read MoreOn Friday, Blue Cross Blue Shield of Nebraska announced they are pulling out of Obamacare marketplace in the state citing
Read MoreWhile health care has not been central to the 2016 Presidential campaign, the election’s outcome will be a major determining
Read More(By Damian Garde for ST A T) T he Food and Drug Administration on Friday approved a lower-cost version of
Read More(By Sharon Begley for ST A T) N EW YORK — There’s been a lot of excitement about immunotherapy 1
Read More(By Jon Hamilton for NPR) There’s growing evidence that a physical injury to the brain can make people susceptible to
Read More(by Arun Rath for NPR) When Harry Selker was working as a cardiologist in the 1970s, clot-busting drugs were showing
Read More(By Pauline Bartolone for California Healthline) At first blush, the tobacco tax measure on California’s November ballot looks pretty straightforward.
Read More